186 related articles for article (PubMed ID: 37563620)
1. Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer.
Fan YC; Fong YC; Kuo CT; Li CW; Chen WY; Lin JD; Bürtin F; Linnebacher M; Bui QT; Lee KD; Tsai YC
Cell Biosci; 2023 Aug; 13(1):147. PubMed ID: 37563620
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
Elaraj DM; Weinreich DM; Varghese S; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Alexander HR
Clin Cancer Res; 2006 Feb; 12(4):1088-96. PubMed ID: 16489061
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.
Klueh U; Antar O; Qiao Y; Kreutzer DL
J Diabetes Sci Technol; 2013 Nov; 7(6):1538-46. PubMed ID: 24351180
[TBL] [Abstract][Full Text] [Related]
4. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
[TBL] [Abstract][Full Text] [Related]
5. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.
Rogier R; Ederveen THA; Boekhorst J; Wopereis H; Scher JU; Manasson J; Frambach SJCM; Knol J; Garssen J; van der Kraan PM; Koenders MI; van den Berg WB; van Hijum SAFT; Abdollahi-Roodsaz S
Microbiome; 2017 Jun; 5(1):63. PubMed ID: 28645307
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.
Somm E; Cettour-Rose P; Asensio C; Charollais A; Klein M; Theander-Carrillo C; Juge-Aubry CE; Dayer JM; Nicklin MJ; Meda P; Rohner-Jeanrenaud F; Meier CA
Diabetologia; 2006 Feb; 49(2):387-93. PubMed ID: 16385385
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome.
Witkin SS; Vardhana S; Yih M; Doh K; Bongiovanni AM; Gerber S
Am J Obstet Gynecol; 2003 Nov; 189(5):1413-7. PubMed ID: 14634579
[TBL] [Abstract][Full Text] [Related]
8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
9. Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.
Hill-Batorski L; Halfmann P; Marzi A; Lopes TJ; Neumann G; Feldmann H; Kawaoka Y
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S329-35. PubMed ID: 26209680
[TBL] [Abstract][Full Text] [Related]
10. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.
Petrasek J; Dolganiuc A; Csak T; Kurt-Jones EA; Szabo G
Gastroenterology; 2011 Feb; 140(2):697-708.e4. PubMed ID: 20727895
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
13. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.
Mohammed S; Sukumaran S; Bajgain P; Watanabe N; Heslop HE; Rooney CM; Brenner MK; Fisher WE; Leen AM; Vera JF
Mol Ther; 2017 Jan; 25(1):249-258. PubMed ID: 28129119
[TBL] [Abstract][Full Text] [Related]
14. α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation.
Abecassis A; Schuster R; Shahaf G; Ozeri E; Green R; Ochayon DE; Rider P; Lewis EC
Cell Mol Immunol; 2014 Jul; 11(4):377-86. PubMed ID: 25000533
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis.
Corr M; Boyle DL; Ronacher LM; Lew BR; van Baarsen LG; Tak PP; Firestein GS
Ann Rheum Dis; 2011 May; 70(5):858-63. PubMed ID: 21216819
[TBL] [Abstract][Full Text] [Related]
16. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma.
Wang CC; Fu CL; Yang YH; Lo YC; Wang LC; Chuang YH; Chang DM; Chiang BL
Gene Ther; 2006 Oct; 13(19):1414-21. PubMed ID: 16724092
[TBL] [Abstract][Full Text] [Related]
18. Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression.
Fan YC; Lee KD; Tsai YC
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33322099
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
20. Negative Immunomodulatory Effects of Type 2 Porcine Reproductive and Respiratory Syndrome Virus-Induced Interleukin-1 Receptor Antagonist on Porcine Innate and Adaptive Immune Functions.
Nedumpun T; Techakriengkrai N; Thanawongnuwech R; Suradhat S
Front Immunol; 2019; 10():579. PubMed ID: 30972072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
